Rare diseases
Investigational molecules
Locations
Back to Hungary58 clinical trials in Tatabanya, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
HungaryStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
HungaryStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
HungaryStudy on the Effectiveness and Safety of LYR-210 and Dexamethasone for Treating Chronic Sinusitis in Adults Without Nasal Polyps
HungaryStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
HungaryStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
HungaryStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
HungaryStudy comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy
HungaryStudy of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer
HungaryStudy of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive research focusing on breast cancer, prostate cancer, and lung cancer treatments, evaluating novel therapeutic combinations and targeted approaches.
Multiple studies exploring immunotherapy combinations and targeted treatments for various cancer stages.
Innovative clinical trials investigating treatments for Crohn's Disease and chronic rhinosinusitis, focusing on long-term management and symptom control.
Research emphasizing both immediate efficacy and sustained therapeutic benefits.
Focused research on Parkinson's Disease treatment options, evaluating long-term safety and effectiveness of novel therapeutic approaches.
Studies aimed at improving quality of life and disease management for patients with neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
